Close

Eleven Biotherapeutics (EBIO) Completes Merger with Viventia Bio; New CEO Named

Go back to Eleven Biotherapeutics (EBIO) Completes Merger with Viventia Bio; New CEO Named

Form 8-K Eleven Biotherapeutics, For: Sep 20

September 21, 2016 7:11 AM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

... More

Form SC 13D/A Eleven Biotherapeutics, Filed by: Flagship Ventures Fund 2007, L.P.

September 19, 2016 4:05 PM EDT

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

... More